<code id='B69C7481EB'></code><style id='B69C7481EB'></style>
    • <acronym id='B69C7481EB'></acronym>
      <center id='B69C7481EB'><center id='B69C7481EB'><tfoot id='B69C7481EB'></tfoot></center><abbr id='B69C7481EB'><dir id='B69C7481EB'><tfoot id='B69C7481EB'></tfoot><noframes id='B69C7481EB'>

    • <optgroup id='B69C7481EB'><strike id='B69C7481EB'><sup id='B69C7481EB'></sup></strike><code id='B69C7481EB'></code></optgroup>
        1. <b id='B69C7481EB'><label id='B69C7481EB'><select id='B69C7481EB'><dt id='B69C7481EB'><span id='B69C7481EB'></span></dt></select></label></b><u id='B69C7481EB'></u>
          <i id='B69C7481EB'><strike id='B69C7481EB'><tt id='B69C7481EB'><pre id='B69C7481EB'></pre></tt></strike></i>

          leisure time

          leisure time

          author:focus    Page View:12
          Trump Campaign Event In Nevada
          Ethan Miller/Getty Images

          WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.

          In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.

          advertisement

          “Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          How to save PrEP access — and even expand it
          How to save PrEP access — and even expand it

          UndertheAffordableCareAct,healthinsurersarerequiredtocoverallcostsassociatedwithpreventivecare—inclu

          read more
          Novo: Oral version of Ozempic leads to 15% weight loss
          Novo: Oral version of Ozempic leads to 15% weight loss

          LISELOTTESABROE/AFP/GettyImagesAnoralversionofsemaglutide,thedrugmarketedasOzempicandWegovy,ledtodra

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          Bispecific antibodies are next new thing in cancer immunotherapy

          IllustrationofaBiTE,Amgen'sbispecificantibodiesAmgenIncancerimmunotherapythesedays,technologyisadvan